ホルモン補充療法市場規模、シェア、成長分析、療法タイプ別、適応症別、地域別-産業予測、2025～2032年

ホルモン補充療法（HRT）の世界市場規模は2023年に289億7,000万米ドルと評価され、2024年の312億3,000万米ドルから2032年には563億5,000万米ドルに成長し、予測期間（2025～2032年）のCAGRは7.8％で成長する展望です。

ホルモン補充療法（HRT）市場は、主にほてりや骨粗鬆症リスクなどの更年期障害関連症状の治療における長年の有効性により、著しい成長を遂げています。この市場拡大には、男性を含む多様な年齢層に影響を及ぼす他のホルモン関連疾患に対する認識と有病率の増加がさらに拍車をかけています。甲状腺疾患の急増も市場の成長に寄与しており、米国甲状腺協会は、アメリカ人の12％が一生のうちに甲状腺疾患を経験すると報告しています。長時間作用型ヒト成長ホルモン（hGH）製品は治療の選択肢を増やし、最近の研究ではHRTがCOVID-19感染と死亡のリスクを下げる可能性が示唆されています。その結果、HRT市場は予測期間中に堅調な拡大が見込まれます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場展望
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主要市場の考察

• 重要成功要因
• 競合の程度
• 主要投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制分析
• ケーススタディ分析
• 特許分析

治療タイプによる世界のホルモン補充療法（HRT）市場規模&CAGR（2025～2032年）

• 市場概要
• エストロゲンと併用補充療法
• 甲状腺ホルモン補充療法
• 成長ホルモン補充療法
• テストステロンホルモン補充療法

適応症による世界のホルモン補充療法（HRT）市場規模&CAGR（2025～2032年）

• 市場概要
• 閉経
• 甲状腺機能低下症
• 男性性腺機能低下症
• 成長ホルモン欠乏症

投与経路による世界のホルモン補充療法（HRT）市場規模&CAGR（2025～2032年）

• 市場概要
• 経口
• 経皮
• 非経口

流通チャネルによる世界のホルモン補充療法（HRT）市場規模&CAGR（2025～2032年）

• 市場概要
• 病院薬局
• 小売薬局・ドラッグストア
• オンライン薬局

世界のホルモン補充療法（HRT）市場規模&CAGR（2025～2032年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他のラテンアメリカ
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主要市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
• 製品ポートフォリオ分析
• セグメント別シェア分析

Global Hormone Replacement Therapy (HRT) Market size was valued at USD 28.97 billion in 2023 and is poised to grow from USD 31.23 billion in 2024 to USD 56.35 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The hormone replacement therapy (HRT) market is witnessing significant growth, primarily due to its longstanding effectiveness in treating menopause-related symptoms such as hot flashes and osteoporosis risks. This expansion is further fueled by increasing awareness and prevalence of other hormone-related conditions affecting diverse age groups, including men. The surge in thyroid disorders, with the American Thyroid Association reporting that 12% of Americans will experience thyroid disease in their lifetime, is also contributing to market growth. Long-acting human growth hormone (hGH) products are enhancing treatment options, while recent studies suggest HRT may lower the risk of COVID-19 infection and mortality. Consequently, the HRT market is poised for robust expansion during the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hormone Replacement Therapy (Hrt) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hormone Replacement Therapy (Hrt) Market Segmental Analysis

Global Hormone Replacement Therapy (HRT) Market is segmented by therapy type, indication, route of administration, distribution channel and region. Based on therapy type, the market is segmented into estrogen and combinations replacement therapy, thyroid hormone replacement therapy, growth hormone replacement therapy and testosterone hormone replacement therapy. Based on indication, the market is segmented into menopause, hypothyroidism, male hypogonadism and growth hormone deficiency. Based on route of administration, the market is segmented into oral, transdermal and parenteral. Based on distribution channel, the market is segmented into hospitals pharmacies, retail pharmacies & drug stores and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hormone Replacement Therapy (Hrt) Market

The global Hormone Replacement Therapy (HRT) market is driven by a pressing need for effective treatments among diverse patient groups, including those facing growth hormone deficiencies, menopausal symptoms in women, and hypogonadism in older men. This medication is available in various forms such as skin and buccal patches, injections, and tablets, which enhances accessibility for patients. As demand surges worldwide, manufacturers are prioritizing the development of innovative drug delivery systems, including transdermal estrogen patches and vaginal estrogen tablets. In response to safety concerns, there is a growing emphasis on low-dose estrogen therapy, alongside new gel-based formulations for estrogen patches and other delivery methods.

Restraints in the Global Hormone Replacement Therapy (Hrt) Market

The Global Hormone Replacement Therapy (HRT) market faces several restraints that may hinder its growth. Various treatment formulations, including patches, gels, capsules, and injections, are available; however, their potential side effects can be a significant deterrent. Issues such as elevated cholesterol levels, blood clots, bloating, and swelling can negatively impact patient perception and adoption. Furthermore, testosterone replacement therapy has been linked to adverse effects including benign prostatic hyperplasia, obstructive sleep apnea, and an increased risk of prostate cancer. The US FDA's concerns regarding the approved indications and the rising cardiovascular risks associated with testosterone products add another layer of complication that may impede market expansion.

Market Trends of the Global Hormone Replacement Therapy (Hrt) Market

The Global Hormone Replacement Therapy (HRT) market is witnessing a significant upward trend, fueled by rising demand in emerging nations and heightened awareness of hormone-related health issues. As more individuals recognize the benefits of HRT, pharmaceutical companies are innovating to develop advanced medications that cater to this unmet need. Notably, the aging population and increasing prevalence of menopause and associated hormone deficiencies in key markets are driving manufacturers to unveil novel product offerings, including combination therapies that enhance efficacy and patient compliance, moving away from traditional long-acting parenteral options. This evolution underscores the dynamic nature of the HRT sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Case Study Analysis
• Patent Analysis

Global Hormone Replacement Therapy (HRT) Market Size by Therapy Type & CAGR (2025-2032)

• Market Overview
• Estrogen and Combinations Replacement Therapy
• Thyroid Hormone Replacement Therapy
• Growth Hormone Replacement Therapy
• Testosterone Hormone Replacement Therapy

Global Hormone Replacement Therapy (HRT) Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Menopause
• Hypothyroidism
• Male Hypogonadism
• Growth Hormone Deficiency

Global Hormone Replacement Therapy (HRT) Market Size by Route Of Administration & CAGR (2025-2032)

• Market Overview
• Oral
• Transdermal
• Parenteral

Global Hormone Replacement Therapy (HRT) Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospitals Pharmacies
• Retail Pharmacies & Drug Stores
• Online Pharmacies

Global Hormone Replacement Therapy (HRT) Market Size & CAGR (2025-2032)

• North America (Therapy Type, Indication, Route Of Administration, Distribution Channel)
  • US
  • Canada
• Europe (Therapy Type, Indication, Route Of Administration, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Therapy Type, Indication, Route Of Administration, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Therapy Type, Indication, Route Of Administration, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Therapy Type, Indication, Route Of Administration, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
• Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TherapeuticsMD Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (now part of Viatris)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan plc (now part of AbbVie)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ipsen S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (GSK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations